Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Triosephosphate isomerase 1 pseudogene 4 (TPI1P4) is a non-functional, non-coding genomic element located on human chromosome 4p11. It is a processed pseudogene derived from the functional TPI1 gene, which encodes the glycolytic enzyme triosephosphate isomerase. Pseudogenes like TPI1P4 result from gene duplication or retrotransposition events and contain disabling mutations, such as frameshifts or premature stop codons, that prevent them from encoding functional proteins. TPI1P4 is not known to have any regulatory function, does not give rise to protein or functional RNA, and has no documented involvement in human diseases or pharmacology. Pseudogenes are typically remnants of once-functional genes rendered inactive by disabling mutations or transcriptional silencing. Some pseudogenes in the human genome can play regulatory roles or produce noncoding transcripts, but there is no evidence this applies to TPI1P4. Clinical, biomarker, or therapeutic relevance for TPI1P4 has not been reported in the literature or major genetic databases.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Triosephosphate isomerase 1 pseudogene 4 (TPI1P4).